Cain Linville
Plastic and Reconstructive Surgery · Houston, TXNPI 1649527193
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (47.8%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. AbbVie accounts for 71.4% of it on its own, with 18 other manufacturers making up the rest. Reporting peaked in 2019 at $8,453 and has fallen 85.8% since, to $1,201 in 2025. Among plastic and reconstructive surgery clinicians in TX with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 279 payments — averaging $70.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$14K
- Sientra, Inc.$2K
- Mentor Worldwide LLC$1K
- Merz North America, Inc.$1K
- Axogen$317
- RTI Surgical, Inc$271
- plus $1K from 13 others
What the payments were for
- Consulting fees$5,79730%
- Speaking & faculty fees$1,5688%
- Travel & lodging$2,85415%
- Food & beverage$9,35648%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 172 | $13,971 |
| Sientra, Inc. | 23 | $1,666 |
| Mentor Worldwide LLC | 36 | $1,321 |
| Merz North America, Inc. | 5 | $1,011 |
| Axogen | 6 | $317 |
| RTI Surgical, Inc | 7 | $271 |
| TELA Bio, Inc. | 4 | $267 |
| Galderma Laboratories, L.p. | 11 | $230 |
| Musculoskeletal Transplant Foundation Inc. | 2 | $148 |
| Davol Inc. | 2 | $79 |
| Integra Lifesciences Corporation | 1 | $52 |
| Wound Management Technologies, Inc | 2 | $44 |
| Bard Peripheral Vascular, Inc. | 1 | $44 |
| Medtronic | 2 | $36 |
| Biocircuit Technologies Inc | 1 | $33 |
| Tepha Inc | 1 | $29 |
| Apyx Medical Corporation | 1 | $23 |
| Baudax Bio Inc. | 1 | $19 |
| Therapeuticsmd, Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ALLODERM$7,052
- NATRELLE$4,255
- STRATTICE$3,896
- NATRELLE SALINE-FILLED BREAST IMPLANTS$3,723
- STRATTICE RECONSTRUCTIVE TISSUE MATRIX BPS$1,861
- REVOLVE$1,861
- XEOMIN$970
- SIENTRA HIGH STRENGTH COHESIVE SILICONE GEL BREAST IMPLANT$706
- MENTOR MemoryGel Resterilizable Gel Sizer$419
- AXOGUARD$367
- AXOGUARD HA+ NERVE PROTECTOR$184
- AxoGuard Nerve Cap$184
- OviTex Reinforced Bioscaffold With Permanent Polymer (OviTex)$166
- CORTIVA ALLOGRAFT DERMIS$144
How this compares
$19,575 in reported general payments places this provider in the 90th percentile of 378 plastic and reconstructive surgery providers in Texas.
See all plastic and reconstructive surgery providers in Texas →
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 11 | $94 |
| Gabapentin | 16 | $64 |
| Meloxicam | 22 | $38 |
| Ondansetron Hcl | 15 | $30 |
Paid to pharmacies, not to this prescriber.
Other plastic and reconstructive surgery in Houston
- Aldona SpiegelHouston$759K
- Charles ButlerHouston$227K
- Michael KlebucHouston$204K
- Patrick GarveyHouston$117K
- Rukmini RednamHouston$113K
- Edward ChangHouston$111K
- Christi BlakkolbHouston$69K
- Justin BroylesHouston$48K
- Pablo PadillaHouston$46K
- Courtney El-ZokmHouston$29K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.